REVEAL GENOMICS®️ ANNOUNCES RESEARCH COLLABORATION IN HER2+ BREAST CANCER

/PRNewswire/ -- REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up that is seeking to revolutionize precision oncology through diagnostic...

Related Keywords

San Antonio ,Texas ,United States ,Hebron ,Israel General ,Israel ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Saram Tolaney ,Patricia Villagrasa Gonzalez ,Aleix Prat ,Sara Tolaney ,University Of Barcelona ,Division Of Breast Oncology ,Hebron Institute Of Oncology ,Women Cancers At Dana Farber Cancer Institute ,Dana Farber Cancer Institute ,Susanf Smith Center ,New England Journal ,Clinical Oncology ,San Antonio Breast Cancer Meeting ,Breast Oncology ,Associate Director ,Dana Farber Cancer ,Hebron Institute ,Reveal Genomics ,Sl ,